Press Releases

AUCKLAND, New Zealand--(BUSINESS WIRE)-- Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been chosen by the VIB (a Life Sciences Research Institute in Belgium) to support therapeutic biologics discovery at its Discovery Sciences group. Bruno Dombrecht, Expert Scientist at VIB Discovery Sciences: &ldquo

OSAKA, Japan--(BUSINESS WIRE)-- Further to the announcement on May 8, 2018, by Takeda Pharmaceutical Company Limited (“Takeda” or the “Company”) regarding the proposed acquisition (the “Acquisition”) of Shire plc (“Shire”), Takeda announces the publication of a circular (the “Circular”) containing a notice of its decision to hold an Extraordinary General Meet

SHENZHEN, China--(BUSINESS WIRE)-- China Hi-tech Fair 2018 will be held with the theme “New Development Concept for High Quality Growth” at the Shenzhen Convention and Exhibition Center on November 14-18, 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/

SHANGHAI--(BUSINESS WIRE)-- Generon Corporation, a leading biopharmaceutical company in China, today announced it received approval for the Company’s Investigational New

SEATTLE--(BUSINESS WIRE)-- Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that on November 7, 2018, the first patient has enrolled (FPFV; first patient first visit) in a study to evaluate Acucela’s leading drug candidate, emixustat hydrochloride (“emixustat”), in

NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia b

CHICAGO--(BUSINESS WIRE)-- Abiomed (NASDAQ: ABMD) announces the results of the FDA

LYON, France--(BUSINESS WIRE)-- POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorder

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Harpoon Therapeutics, Inc. (“Harpoon”), a clinical-stage immunotherapy company developing a novel class of T cell engagers, announced today the closing of a $70 million Series C equity financing. OrbiMed served as the lead new investor, along with new investors Cormorant, Ridgeback Capital Investments, Lilly Asia Ventures (LAV) and NS Investment. Harpoo

LA ROCHELLE, France--(BUSINESS WIRE)-- Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181111005031/en/

DEARBORN, Mich.--(BUSINESS WIRE)-- EnvisionTEC, a leading global manufacturer of desktop and full-production 3D printers and materials, today announced that it will be debuting the industry’s first ever DLP-based 3D printer utilizing a true 4K projector with artificial intelligence. The Perfactory P4K will be on display at formnext, an international exhibition and conference on the next generation of manu

STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announced the complete data from the Phase 1 trial evaluating the safety and immunogenicity of TG1050 in patients with chronic hepatitis B. The data have been presented at the American Association for the Study of Liver Disease

SEATTLE--(BUSINESS WIRE)-- OtoNexus Medical Technologies is developing the world’s first device to help pediatricians instantly and accurately diagnose middle ear infections (Otitis Media) in children and adults. It can help determine both the presence of infection, and more importantly, the type of infection, which will allow pediatricians to confidently differentiate when and when not to prescrib

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca today announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for FARXIGA (dapagliflozin). The data were presented as a late-breaking abstract (#19485) at the American Heart Association (AHA) Scientific Sessions 2018 in Chicago, IL, and simultaneously published in the

WASHINGTON--(BUSINESS WIRE)-- Retired Col. Edward Shames, the last surviving officer of the historic “Easy” Company, 2nd Battalion of the